Pamela F. Weiss, MD, MSCE

Pamela F. Weiss, MD, MSCE, is an attending physician in the Division of Rheumatology at The Children's Hospital of Philadelphia.

Areas of Expertise: Enthesitis-related arthritis, Juvenile arthritis, Juvenile spondyloarthritis, Vasculitis
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)

  • Background

    Pamela F. Weiss, MD, MSCE, is an attending physician in the Division of Rheumatology at The Children's Hospital of Philadelphia, and an assistant professor of Pediatrics at the Perelman School of Medicine at the University of Pennsylvania.

    Dr. Weiss is the recipient of the Arthritis Foundation Professional Educator award (2012) and the Spondylitis Association of America-Jane Bruckel Young Investigator Award (2014). She is also vice-chair of the Childhood Arthritis and Rheumatology Research Alliance’s JIA Research committee.

    Her research on the clinical and imaging features associated with early juvenile spondyloarthritis (JSpA) has led to several significant publications, a national reputation in juvenile idiopathic arthritis (JIA) research, and continuous foundation and federal funding. She strives to provide superior clinical care for children with rheumatic disease, use pediatric rheumatology as a platform to share her enthusiasm with students at all levels, and make meaningful contributions to advancing the care of children with JSpA through clinical research activities.

  • Education and Training

    Medical School

    MD - Albert Einstein College of Medicine, New York, NY

    Residency

    Pediatrics - The Children's Hospital of Philadelphia, Philadelphia, PA

    Fellowship

    Pediatric Rheumatology - The Children's Hospital of Philadelphia, Philadelphia, PA

    Additional Training

    MSCE - University of Pennsylvania School of Medicine, Center for Clinical Epidemiology and Biostatistics, Philadelphia, PA

    Board Certification

    Pediatric Rheumatology
    Pediatrics

  • Titles and Academic Titles

    Attending Physician

    Assistant Professor of Pediatrics, Perelman School of Medicine at the University of Pennsylvania

  • Departments and Services
  • Research Interests

    Pharmacoepidemiology and outcomes research in pediatric juvenile idiopathic arthritis (JIA) and juvenile spondyloarthritis

  • Publications

    Papers

    2015

    Weiss PF, Xiao R, Biko DM, Johnson AM, Chauvin NA. Detection of Inflammatory Sacroiliitis in Children With Magnetic Resonance Imaging: Is Gadolinium Contrast Enhancement Necessary? Arthritis Rheumatol. 2015 May;67(8):2250-6. doi: 10.1002/art.39159.

    2014

    Weiss PF, Colbert RA, Xiao R, Feudtner C, Beukelman T, Morgan DeWitt E, Pagnini I, Wright TB, Wallace CA. Development and retrospective validation of the juvenile spondyloarthritis disease activity (JSpADA) index. Arthritis Care Res (Hoboken). 2014 Dec;66(12):1775-82. doi: 10.1002/acr.22411.

    Weiss PF, Chauvin NA, Klink AJ, Localio R, Feudtner C, Jaramillo D, Colbert RA, Sherry DD, Keren R. Detection of enthesitis in children with enthesitis-related arthritis: dolorimetry compared to ultrasonography. Arthritis Rheumatol 66(1): 218-27, Jan 2014.

    Ringold S*, Weiss PF*, Colbert RA, Dewitt EM, Lee T, Onel K, Prahalad S, Schneider R, Shenoi S, Vehe RK, Kimura Y; for the Juvenile Idiopathic Arthritis Research Committee of the Children's Arthritis and Rheumatology Research Alliance (CARRA) (*co-first authors), Childhood arthritis and rheumatology research alliance consensus treatment plans for new onset polyarticular juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2013 Dec 10.

    Weiss PF, Klink AJ, Faerber J, Feudtner C. The pediatric rheumatology quality of life scale: validation of the English version in a US cohort of juvenile idiopathic arthritis. Pediatr Rheumatol Online J. 2013 Nov 8;11(1):43.

    Ringold S*, Weiss PF*, Beukelman T, Morgan-DeWitt E, Ilowite N, Kimura Y, Laxer RM Lovell D, Nigrovic P, Robinson A, Vehe R (*co-first authors). 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Care Res (Hoboken). 2013 Oct;65(10):1551-63.

    Ringold S* and Weiss PF*, Beukelman T, Morgan-DeWitt E, Ilowite N, Kimura Y, Laxer RM Lovell D, Nigrovic P, Robinson A, Vehe R (*co-first authors). 2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening among children receiving biologic medications. Arthritis Rheum. 2013 Oct;65(10):2499-512.

    Weiss PF, Beukelman T, Schanberg LE, Kimura Y, Colbert RA; CARRA Registry Investigators. Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry. J Rheumatol. 2012 Dec;39(12):2341-51

    Beukelman T, Ringold S, Davis TE, DeWitt EM, Pelajo CF, Weiss PF, Kimura Y; CARRA Registry Investigators. Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. J Rheumatol. 2012 Sep;39(9).

    DeWitt EM, Kimura Y, Beukelman T, Nigrovic PA, Onel K, Prahalad S, Schneider R, Stoll ML, Angeles-Han S, Milojevic D, Schikler KN, Vehe RK, Weiss JE, Weiss P, Ilowite NT, Wallace CA. Juvenile Idiopathic Arthritis Disease-specific Research Committee of Childhood Arthritis Rheumatology and Research Alliance: Consensus treatment plans for new-onset systemic juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2012 Jul;64(7):1001-10.